Member Info for Fevertreeman

All well and good but Newland & Griffiths have consistently misled or fudged or obfuscated investors - that is the sorry truth, and there is a tonne of evidence to support that statement. What is frankly astonishing is the Board seems utterly unable to hold Newland d to account for his misleading pronouncements or to rein him in.

Deluge of sells this afternoon

Exactly correct. One of the least edifying aspects to Newland and Griffiths is their refusal to accept responsibility for forecasting. It has been one of the reasons why credibility has been lost. Newland’s ludicrous comment suggesting analyst forecasts have been reached w/o management hints, steers and discussions further undermines his credibility. He seems to think he’s the smartest chap in the room, which on the evidence to date is simply vainglorious. If he and Griffiths can’t make their own numbers after yet another bloody raise then one of them needs to walk the plank. The Board here is supine

He retires at the blinking AGM I.e today

So Bungle Bundred retires as one of the worst chairs of a listed company to be replaced by ……? Oh that’s right, they haven’t got a chair to announce. The key management position remains unfilled - that speaks volumes. As long as Johnson remains as CEO without any checks and balances in form of strong, independent chair which Bungle disastrously wasn’t , expect more trouble ahead

It wasn’t a 25k contract lost. The Amey contract was You 7% of Group revenue & 10% of Group Adjusted EBITA.

Newland having burnt thro £140m or so of s/holders monies has sod all to show for it. As s/o has pointed out Verici has same mkt cap, 3x the revenues, longer cash runway, and a management team committed to meeting milestones which Newland Griffiths and the board has never met. Oh and them there the small matter of Thermo Fisher….

No replacement Chairman announced ; Johnson still in place as CEO ( he should have moved roles); CFO has been complicit in the financial shambles of last 12 months; only COO performing properly

Given Ashmore’s stellar performance as CEO, the question must be being asked by his two PE masters who are the key players here as to whether they backed the wrong horse and strategy

Summer lull so time to reflect on Newland’s leadership and track record. One consistent theme is that Newland consistently hypes the potential but then fails consistently to deliver, either by missing revenue by a country mile or by not signing any deals. From a peak of well over a pound, the decline has been spectacular: yes, end of zero interest rates is a big factor as support for loss-making, blue sky companies dried up, and yes, the bio pharma sector was hit but these factors alone don’t explain why after 10s of millions of cash raised, AGL is still barely ticking over in revenue terms. Newland has yet to prove his CEO credentials. He apparently failed to lay the commercial groundwork ahead of FFA approval which seems to have caught him by surprise; he then compounded matters by shafting s/holders with an 80p raise that was then followed all too swiftly with a revenue warning. And it’s been downhill ever since. One of the biggest accusations properly laid at his door is that the constant stream of hyped, breadcrumb laying remarks designed to pump the share price that are not anchored to any facts. That £6.4m for current year that AN claims is nothing to do with him guv, did not land out of thin air but was guided to by the company (as anyone who’s been an analyst would know). The issue is that we still lack any detail of how AN got to the 3x prior year fig. Since then he’s raised again, and he would have needed to reassure the placees that they weren’t going to get shafted again with the FY figs.. give he has form, he is potentially playing with fire again….

It isn't fully funded.....Newland is the hypemeister & Griffiths is as slippery as they come. Griifhts has already said they have a funding gap whcih would have factored in Newland forecast £6.4m of revs for this year; with 1-1.3m (talk about a bloody big range 3o% ) predicted for 1H, Newland will have to postpone Rock, Salcombe, Bahamas or St Tropez summer hols to get revenues through the door.

Many of us have been invested here for ages...so we have a much better handle on trading patterns...and Newland's management style

Or even £15....the sky's truly the limit with Newland's blue-sky forecasting,

Chortle chortle chortle............you'll see the mo the sp hit 16+ mark it got hit by a raft of sellers in decent sizes. Until Newland produces concrete, sustained evidence of commercial success (and cuts out his cavalier approach to revenue guidance aka think of a number and hope) this will continue to be a trading stock, as folk make 10 -20 pc round tripping, buying in low teens and selling in mid-high teens! The market just doesn't trust Newland

Don't disagree but management have a role to play in beating the drum for the company, and dipping their hands into their pockets sends a signal. Given that sp is now well below the raise, not sure why the Board & management aren't investing

Random figs plucked out of nowhere! Investing as opposed to punting is based on modelling future revenues & profits, discounted back to reach a share price target. As AGL doesn't have much in way of revs, is loss-making, and burning cash price targets are utterly meaningless at present. Blue-sky investments are like that until they're not. Newland's key focus has to be on making the rev projections he threw to the market of £6.4m, in order to do which he must sign multiple deals between now & Dec 31. We're half way thro the year, so if he can deliver a major boost in revs 2H then he gets to restore some of his lost credibility. In the meantime, share price moves sole on sentiment

I would add one other comment to the mix...management succession....if you were the team at Affini, given the age of the Abdullahs and their lack of ambition, energy, call it what you will, then the enlarged group offers a bigger listed platform for their management team.

EC, this remains a classic trading stock: trading range has been 13p-25p for quite a while. It's a far cry from the 80p raise (and the 130s upwards on FDA approval), which is when the rot set in: Newland then delivered a revenue warning that cratered confidence, and meant some big holder bailed out. AGL will continue to be aq trading stock (can be quite profitable if timed right) until Newland can prove he can put together a string of meaningful commercial deals (and not the odd £350k, 500k phase 1 trial) that prove the parsortix investment case. Frist step is to deliver the £6.4m revs he confidently predicted for current year. As you know we are miles off it to date. perhaps tomorrow Newland will begin his rehabilitation in earnest...who knows

SP didn't stay above 15 for very long.....a flurry of sell orders hitting the bid. About £30k sold into the rise. Still a lot of scepticism around Newland - unsurprising given his history of hype, missed forecasts, & cash burn. I do hope that he has something positive to say tmrw, otherwise cue disappointment and sp back down again

Just for clarity 's sake, Ian Lyall who wrote the article is MD of proactive (and an experienced financial hack). it is entirely possible that FTI were not involved in placing it with The Mail, given the Mail's relationship with Proactive. But, Lyall clearly had to persuade the financial editor to run with it......Newland has appeared on Proactive fairly often, so will have a direct line into Lyall. Clearly Lyall thinks his timing is good....lets see